Rize Oncology Inc. (CSE:RIZE)
Canada flag Canada · Delayed Price · Currency is CAD
0.0300
0.00 (0.00%)
Apr 25, 2025, 4:00 PM EDT

Rize Oncology Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
2325--
Upgrade
Market Cap Growth
125.00%125.00%-67.83%---
Upgrade
Enterprise Value
12-02--
Upgrade
Last Close Price
0.030.090.040.10--
Upgrade
PB Ratio
1.422.190.861.92--
Upgrade
P/TBV Ratio
1.422.190.861.92--
Upgrade
Debt / Equity Ratio
------1.57
Upgrade
Quick Ratio
13.9813.9835.3320.540.840.37
Upgrade
Current Ratio
14.3514.3536.5622.241.740.37
Upgrade
Return on Equity (ROE)
-44.40%-44.40%-42.64%-170.34%-4122.37%-
Upgrade
Return on Assets (ROA)
-28.28%-28.28%-27.84%-92.74%-492.06%-153.75%
Upgrade
Return on Capital (ROIC)
-29.67%-29.67%-28.93%-106.58%-1015.04%-159.59%
Upgrade
Earnings Yield
-34.88%-22.73%-58.66%-48.18%--
Upgrade
Buyback Yield / Dilution
16.52%16.52%-7.75%-20.45%-32.93%-3729.11%
Upgrade
Updated Nov 22, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.